Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients.

[1]  T. Day,et al.  Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review. , 2014, Oral surgery, oral medicine, oral pathology and oral radiology.

[2]  M. Pimentel,et al.  Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands. , 2014, Anticancer research.

[3]  A. Eisbruch.  Radiotherapy: IMRT reduces xerostomia and potentially improves QoL , 2009, Nature Reviews Clinical Oncology.

[4]  K. Sultanem,et al.  Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation‐induced xerostomia , 2009, Head & neck.

[5]  W. Brenner,et al.  The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  M. Navazesh,et al.  Measuring salivary flow: challenges and opportunities. , 2008, Journal of the American Dental Association.

[7]  A. Vissink,et al.  Optimum dose range for the amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  A. Carvalho,et al.  A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. , 2007, Oral oncology.

[9]  Avraham Eisbruch,et al.  Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[10]  Robert L. White,et al.  Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. , 2006, The journal of supportive oncology.

[11]  J. Epstein,et al.  The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[12]  D. Brizel,et al.  How should we measure and report radiotherapy-induced xerostomia? , 2003, Seminars in radiation oncology.

[13]  M. Hareyama,et al.  The changes in irradiated salivary gland function of patients with head and neck tumors treated with radiotherapy. , 2003, Japanese journal of clinical oncology.

[14]  D. Robinson,et al.  Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  G. Lockwood,et al.  A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[16]  J. Horiot,et al.  Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  R. Müller,et al.  Radiation-induced hyposalivation and its treatment with oral pilocarpine. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[18]  F. Hilgers,et al.  Scintigraphic assessment of salivary function and excretion response in radiation‐induced injury of the major salivary glands , 1994, Cancer.

[19]  J. Epstein,et al.  A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study. , 1994, Oral surgery, oral medicine, and oral pathology.

[20]  Everett Hc.  The use of bethanechol chloride with tricyclic antidepressants. , 1975 .

[21]  H. C. Everett.  The use of bethanechol chloride with tricyclic antidepressants. , 1975, The American journal of psychiatry.